#LCSM Chat topic 11/17– FB Live Q&A with NCI on Immunotherapy and Clinical Trials

For Lung Cancer Awareness Month, the National Cancer Institute (NCI) is once again partnering with #LCSM Chat for a special event. During the first half of our November 17 tweetchat, which starts at the usual 8 PM Eastern time (5 PM Pacific), the NCI’s Dr. Shakun Malik (head of thoracic oncology therapeutics) and Janet Freeman-Daily (lung cancer patient/activist and founding member of #LCSM Chat) will have a 30-minute Facebook Live question and answer session on the topic of “Immunotherapy for Lung Cancer: New Research and Clinical Trials.”  The Facebook Live event will… Read More

#LCSM Chat Topic 10/23: How can we help new stage IV #lungcancer patients consider 2nd opinions, mutation testing and clinical trials?

Most patients experience a period of stunned disbelief or shock when they hear a diagnosis of “metastatic lung cancer.”  For those who are offered treatment options, the first few months revolve around medical appointments.  Others may only be told to go home and get their affairs in order.  Patients and family members may be in denial, or trying to process what all those dismal survival statistics mean for their future. It might be the first time the patient or a family member has had to confront the possibility of death for themselves… Read More

December 5 #LCSM Chat Topic – Is the System of Clinical Trials Fair For Patients?

By Dr. H. Jack West IS THE SYSTEM OF CLINICAL TRIALS FAIR FOR PATIENTS? DO YOU BELIEVE IN IT?  I just watched the movie “Dallas Buyers Club”, about the challenges of getting new drugs for HIV/AIDS just as the first effective treatments were being identified in early clinical trials. It portrays the DEA, FDA, and medical establishment as essentially obstructing the process of patients getting access to life-sustaining treatments, and it led me to wonder whether patients and caregivers feel that the system of novel agents being tested in clinical trials is… Read More